First elected: 7th May 2015
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
Call a General Election
Gov Responded - 6 Dec 2024 Debated on - 6 Jan 2025 View Dawn Butler's petition debate contributionsI would like there to be another General Election.
I believe the current Labour Government have gone back on the promises they laid out in the lead up to the last election.
These initiatives were driven by Dawn Butler, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Dawn Butler has not been granted any Urgent Questions
Dawn Butler has not been granted any Adjournment Debates
A Bill to make provision about the use of the title of nurse; and for connected purposes.
A Bill to require the Leader of the House of Commons to move a Motion asserting the equal right of all Members of the House of Commons to participate in proceedings and establishing mechanisms for MPs unable to attend Westminster to vote remotely and to participate remotely in proceedings, including debates and general committees.
A Bill to make provision in connection with coronavirus; and for connected purposes.
A Bill to require the Leader of the House of Commons to move a Motion asserting the equal right of all Members of the House of Commons to participate in proceedings and establishing mechanisms for MPs unable to attend Westminster to vote remotely and to participate remotely in proceedings, including debates and general committees.
Special Educational Needs and Disabilities (Training in Schools) Bill 2024-26
Sponsor - Nesil Caliskan (Lab)
Clean Air Bill 2022-23
Sponsor - Geraint Davies (Ind)
Bullying and respect at work Bill 2022-23
Sponsor - Rachael Maskell (LAB)
Flexible Working Bill 2021-22
Sponsor - Tulip Siddiq (Lab)
Housing and Homelessness (Local Accommodation Duty) Bill 2019-21
Sponsor - Karen Buck (Lab)
Football (Regulation) Bill 2019-21
Sponsor - Helen Grant (Con)
Business Standards Bill 2019-21
Sponsor - John McDonnell (Lab)
There is currently a shortage of some medicines used to treat tuberculosis (TB), non-tuberculous mycobacteria, and other conditions. However, as a result of measures taken, the supply position has significantly improved. Supplies to the market were delayed following regulatory requirements that increased the complexity of the manufacturing process to address serious quality concerns. This was compounded by delivery delays and increased pressure on the products that remain available.
On 21 July 2025, the shortage was designated by the Medicines Shortage Response Group (MSRG) as Tier 4, the highest impact on patients and the system, given the risk to patient and public health. Following a Medicines Supply Notification (MSN) to the system in April, a National Patient Safety Alert was published on 29 July 2025. This provided guidance to clinical teams on prioritising patient care and managing stock. Updates to the issue, including the current status and resupply dates, are regularly maintained via the online Medicines Supply Tool managed by NHS England and the Department.
The situation has improved following ongoing engagement with suppliers and enhanced support from importers. There is now sufficient stock for the treatment of latent TB to continue as normal, and MSRG agreed on 13 October that the issue should be deescalated to a Tier 3, and a new MSN was issued to the system on 23 October 2025.
An Incident Management Team managed the shortage in its most acute phase, led by NHS England and with a broad wider stakeholder group, including the Department and the UK Health Security Agency, and a Supply Chain Management group has co-ordinated the allocation and distribution of the available stock across all four nations.
Thanks to this cross-system collaboration and clinically-led strategy to manage current supplies, the sourcing of additional stock, and the effective prioritisation of the existing supply, the stock levels of many licensed products have improved.
NHS England continues to engage with all relevant suppliers to understand usage and expected resupply dates as well as with specialist importers of unlicensed products to understand their ability to cover the initial and future deficit. Plans are underway to ensure that when further licensed stock becomes available, we can control allocation via wholesalers to enable fair distribution of stock.
Medium to longer-term planning is underway to address ongoing and future challenges in TB medicine supply.
No data relating to patients’ DNA is included in the datasets processed in the NHS Federated Data Platform provided by a consortium led by Palantir. Faculty had no access to patient DNA data as part of any contract with the Department of Health and Social Care or NHS England.
No data relating to patients’ DNA is included in the datasets processed in the NHS Federated Data Platform provided by a consortium led by Palantir. Faculty had no access to patient DNA data as part of any contract with the Department of Health and Social Care or NHS England.
The pause on processing asylum claims and settlement protection applications from Syrian nationals has been lifted.
We are working through the outstanding cases in line with the relevant published policy guidance taking into account the latest published country policy information on Syria. Each application will be considered on its individual merits and some cases may require further consideration and evidence gathering.
We will not remove anyone to their own or any country where they would face persecution or serious harm.
The department has set out the costs of the scheme and provided further details to clarify this: Breakdown of Home Office costs associated with the MEDP with Rwanda and the Illegal Migration Act 2023 - GOV.UK.
For a variety of reasons, including issues around commercial sensitivities, we do not expect to provide a further breakdown of IT-related expenditure, but as the Home Secretary has made clear, our work now is to repurpose as much of this money as possible to clear the asylum backlog and move out of hotels.
Tax policy is a matter for fiscal events.
The Government keeps all tax policy under review.